Autopsy report · NCT03587129

Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer

“No patient enter this study.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 11 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

First Affiliated Hospital of Harbin Medical University

Sponsor type

University, hospital or other

Conditions

Ovarian Cancer

Interventions

Apatinib

Participants

1

Sites

1

Countries

China

Trials that died the same way

• Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain
  “No patients enrolled in the study.” (86% match in meaning)
• Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
  “no patient enrolled.” (78% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (77% match in meaning)
• Energy Expenditure and Gastric Bypass Surgery
  “no patients enrolled.” (76% match in meaning)
• Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
  “No patients recruited.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.